How do I apply topical fusidic acid (Fucidin) for impetigo in a child over 2 months old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How to Apply Topical Fusidic Acid (Fucidin) for Impetigo in Children Over 2 Months

While fusidic acid is effective for impetigo, mupirocin 2% ointment applied three times daily for 5-7 days is the preferred first-line topical treatment recommended by the Infectious Diseases Society of America for children with impetigo. 1, 2

Application Technique for Fusidic Acid

If fusidic acid is being used, follow this protocol:

Pre-Application Preparation

  • Gently wash the affected area with soap and water before each application to remove crusts and debris, which enhances antibiotic penetration 3
  • Soak honey-colored crusts with warm, soapy water to soften them prior to medication application 3
  • Pat the area dry with a clean towel

Application Protocol

  • Apply fusidic acid 2% cream or ointment to the affected lesions three times daily 4, 5
  • Use the cream formulation for weeping or moist lesions that do not require a dressing 5
  • Use the ointment formulation for dry lesions or when applying a dressing over the area 5
  • Continue treatment for 5-7 days 2, 6
  • Cover treated lesions with clean, dry bandages when possible to prevent spread to others 1, 6

Key Advantages of Fusidic Acid

  • Fusidic acid penetrates deeply into skin layers, reaching high antimicrobial concentrations even in damaged epidermis 7
  • It demonstrates potent activity against Staphylococcus aureus (including methicillin-resistant strains) and Streptococcus pyogenes, the primary pathogens in impetigo 4, 7
  • The medication has a low risk of contact sensitization due to its large steric structure 7

When to Escalate Treatment

Switch to oral antibiotics if:

  • No improvement occurs after 48-72 hours of topical therapy 2, 6
  • The impetigo is extensive (multiple lesions or >100 cm² total area) 3, 6
  • Systemic symptoms develop (fever, spreading redness, increasing pain) 2, 3
  • Topical application is impractical due to lesion location or extent 6

Oral antibiotic options include: cephalexin, dicloxacillin, or clindamycin for 5-10 days 1, 3, 6

Critical Infection Control Measures

  • Keep the child home from school/daycare for at least 24 hours after starting antibiotic treatment 3
  • Trim fingernails short to reduce scratching and transmission 3
  • Do not share towels, washcloths, clothing, or bedding until treatment is complete 3
  • Wash all linens in hot water daily during the first few days of therapy 3
  • Examine siblings and close contacts for new lesions, as impetigo spreads easily within households 3

Common Pitfall

Caution: Emerging fusidic acid resistance has been documented with repeated or prolonged use, with resistance rates increasing from 8% to 58% in one study of eczema patients 8. This reinforces why mupirocin remains the guideline-recommended first-line agent for impetigo 1, 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Perioral Impetigo Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Impetigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Fusidic acid in dermatology.

The British journal of dermatology, 1998

Research

Comparative trial of fucidin ointment and fucidin cream in skin sepsis.

The Journal of international medical research, 1980

Guideline

Treatment of Scalp Impetigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fusidic acid in skin infections and infected atopic eczema.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.